Trexeva Plus 2,5/0,625 mg & 5/1,25 mg FC tablets
PDF Leaflet Revision Date: 08 October 2024
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of essential hypertension.
Dosage (summary)
One tablet daily, preferably in the morning before a meal.
Special Populations
- Elderly
- Renal impairment
Pregnancy & Breastfeeding
Contraindicated during pregnancy and lactation.
Key Drug Interactions
- Lithium
- Aliskiren
- Potassium-sparing diuretics
Contraindications
- Hypersensitivity to perindopril or indapamide
- Severe renal impairment
- Pregnancy and lactation
- History of angioedema
Common side effects
- Dizziness
- Hypotension
- Cough
- Hypokalaemia
Counselling Points
- Take in the morning before meals
- Report any signs of allergic reactions
- Regular monitoring of blood pressure and electrolytes
Serious warnings
- Risk of hypotension in volume-depleted patients
- Angioedema risk
- Monitor renal function
Important Disclaimer
The Trexeva Plus 2,5/0,625 mg & 5/1,25 mg FC tablets professional information leaflet below is the property of Teva Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
